A study by researchers from Detroit Medical Center and Wayne State University highlights the risk of Clostridiodes difficile infection (CDI) among COVID-19 patients linked to antibiotic use. The findings appeared in Emerging Infectious Diseases.
CARB-X today announced an award of up to $1.26 million to Facile Therapeutics of Belmont, California, to develop a new oral drug for recurrent Clostridioides difficile infections.
A low-intensity, multifaceted stewardship intervention implemented at nursing homes was associated with improved antibiotic prescribing for urinary tract infections (UTIs), US researchers reported today in JAMA Internal Medicine.
The Democratic Republic of Congo (DRC) reported one more Ebola infection, raising the number of recent cases in Beni to seven.
The patient is a 39-year-old woman who had been in isolation since her daughter died from Ebola on April 20, Reuters reported yesterday. Her illness raises the outbreak total to 3,462, including 2,267 deaths, according to the World Health Organization (WHO) online dashboard.
Applying diagnostic stewardship to molecular testing for Clostridioides difficile infection (CDI) at a hospital system in California was associated with to a significant reduction in testing, cases, and costs, researchers reported today in Infection Control and Hospital Epidemiology.
The findings suggest that prevention efforts, particularly in hospitals, are yielding benefits.
A study today in Infection Control & Hospital Epidemiology reports a high prevalence of antibiotic allergy labels (AALs) in Australian nursing homes.
A computerized clinical support tool implemented at an academic medical center helped reduce rates of Clostridioides difficile testing without an associated increase in adverse events in patients whose tests were prevented, researchers from the University of Virginia (UVA) School of Medicine reported today in Open Forum Infectious Diseases.
The drugs were linked to a more than 70% increase in the odds of intestinal colonization with resistant bacteria.
A major reduction in the use of fluoroquinolones has driven a 12% decrease in total antibiotic use in Canadian hospitals in recent years, according to a new study in Antimicrobial Resistance and Infection Control.
